A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer
Clinical trial NCT04340193 · COMPLETED
Trial details
- NCT number
- NCT04340193
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-14
- Primary completion
- 2023-12-12
- Enrollment
- 26
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.